drugset / Trial / NCT03782103

In-vivo Efficacy of Patient Preoperative Prep, ZuraPrep (ZP)

NCT03782103 ↗

Phase 3 Completed 156 enrolled Zurex Pharma, Inc.
RandomizedParallel-groupSingle-blindPrevention

Summary

The objective of the study is to demonstrate the antimicrobial efficacy of the Zurex Preoperative Prep (ZuraPrep - clear) on skin flora of the abdomen and inguinal regions of human subjects.

Timeline

Start
2019-01-25
Primary completion
2019-05-12
Completion
2019-09-26

Outcome

Met primary endpoint

registry Mean Difference (Final Values) 2.8535 (95% CI 2.5415 to 3.1655) NCT03782103 ↗

registry Mean Difference (Final Values) 1.8208 (95% CI 1.6153 to 2.0264) NCT03782103 ↗

Drugs

EvaluationDrugModalityDoseRoute
Comparator ChloraPrep Other / unclassified 2 % Topical
Comparator ChloraPrep Other / unclassified 70 % Topical
Subject Isopropyl alcohol Other / unclassified 70 % Topical

Indications

No indication recorded.